Timed cerebellar stimulation with immersive virtual reality to boost social prediction

Spatiotemporal Entrainment as Innovative Neuromodulation Targeting Cerebello-cerebral Circuits for Enhancing Rehabilitation Outcomes of Cognitive and Social Skills in Progressive and Acquired Cerebellar Diseases

NA · I.R.C.C.S. Fondazione Santa Lucia · NCT07500103

This trial will try personalized cerebellar HD-tACS together with immersive virtual reality to improve social prediction in adolescents and young adults with congenital cerebellar malformations and in adults with degenerative cerebellar atrophy.

Quick facts

PhaseNA
Study typeInterventional
Enrollment60 (estimated)
Ages12 Years and up
SexAll
SponsorI.R.C.C.S. Fondazione Santa Lucia (other)
Locations2 sites (Pavia and 1 other locations)
Trial IDNCT07500103 on ClinicalTrials.gov

What this trial studies

This is a randomized, double-blind, sham-controlled trial run in two clinical cohorts (30 patients with congenital cerebellar malformations and 30 with degenerative cerebellar atrophy). Participants receive eight consecutive daily 1-hour immersive virtual reality sessions targeting social prediction while simultaneously receiving either EEG-guided active High-Definition transcranial Alternating Current Stimulation (HD-tACS) to the cerebellum or sham stimulation. Allocation is 1:1 active versus sham using computer-generated blocked randomization with blinding of participants and assessors. Outcomes are measured at baseline, immediately after the 8-day intervention, and at a two-month follow-up to examine short- and medium-term effects.

Who should consider this trial

Good fit: Ideal candidates are people aged 12–32 with congenital cerebellar malformations (IQ ≥50) or adults with degenerative cerebellar atrophy (IQ ≥75) who have predominantly cerebellar damage, intact enough motor/visual function to perform the tasks, and no contraindications to tACS.

Not a fit: Patients with extra-cerebellar lesions, severe motor or visual impairments, diagnosed autism or other neurodevelopmental/psychiatric conditions that would prevent task participation, or any contraindication to tACS are unlikely to benefit from this protocol.

Why it matters

Potential benefit: If successful, the approach could improve patients' ability to anticipate others' intentions and enhance everyday social interactions.

How similar studies have performed: Small prior studies suggest cerebellar neuromodulation and virtual-reality training can alter networks and improve some cognitive functions, but the combined EEG-guided HD-tACS plus immersive social VR approach in cerebellar patients is largely novel.

Eligibility criteria

Show full inclusion / exclusion criteria
Inclusion Criteria for patients with cerebellar malformation include:

* Documented malformations confined to the cerebellum confirmed by a 3T brain MRI scan;
* Age ranging from 12 to 32 years old;
* IQ \>= 50;
* Absence of extra-cerebellar malformations on conventional brain MRI scan.

Inclusion Criteria for patients with degenerative cerebellar atrophy include:

* Evidence of diffuse cerebellar atrophy;
* More than 6 months of illness;
* IQ \>=75;
* Absence of any cortical lesion on conventional brain MRI scans

Exclusion Criteria for both groups include:

* Presence of severe motor and visual impairments, as well as neurodevelopmental (i.e., autism), neurological or psychiatric disorders that could interfere with task execution and protocol compliance;
* Presence of any contraindication for tACS.

Where this trial is running

Pavia and 1 other locations

Study contacts

How to participate

  1. Review the eligibility criteria above with your treating physician.
  2. Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
  3. Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.

View on ClinicalTrials.gov →

Conditions: Cerebellar Degeneration, Cerebellar Malformation, Cerebellum, Social prediction, tACS, Virtual Reality

Last reviewed 2026-05-15 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.